Human RANK/TNFRSF11A (Research Grade Denosumab Biosimilar) Antibody, Novus Biologicals™

Human Monoclonal Antibody

Catalog Number	Mfr. No.	Quantity
MAB11492100	R&D Systems MAB11492100	100 μg
MAB11492SP	R&D Systems MAB11492SP	25 μg

Description

RANK/TNFRSF11A Monoclonal antibody specifically detects RANK/TNFRSF11A in Human samples. It is validated for ELISA

Specifications

• Antigen: RANK/TNFRSF11A
• Applications: ELISA
• Conjugate: Unconjugated
• Host Species: Human
• Target Species: Human
• Gene Accession No.: Q9Y6Q6
• Gene ID (Entrez): 8792
• Isotype: IgG1
• Purification Method: Protein A or G purified from hybridoma culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.

• Clone: Hu200
• Classification: Monoclonal
• Form: Purified
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. See Certificate of Analysis for details. *Small pack size (-SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
• Gene Alias: CD265, CD265 antigen, FEO, loss of heterozygosity, 18, chromosomal region 1, ODFR, ODFROSTS, OFE, OPTB7, Osteoclast differentiation factor receptor, PDB2, RANKLOH18CR1, Receptor activator of NF-KB, receptor activator of nuclear factor-kappa B, TNFRSF11A, TRANCE R, TRANCER, tumor necrosis factor receptor superfamily member 11A, tumor necrosis factor receptor superfamily, member 11a, activator of NFKB, tumor necrosis factor receptor superfamily, member 11a, NFKB activator
• Immunogen: Mouse myeloma cell line NS0-derived recombinant human RANK/TNFRSF11A, extracellular domain, Accession # Q9Y6Q6
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.